NASDAQ
Ernexa Therapeutics Inc. - Warrants (ERNAW)
♥ 467 Thanks from members
Ernexa Therapeutics Warrants (ERNAW) reflect volatile micro-cap biotechnology sentiment, tracking the common stock (ERNA) as the company approaches its critical Q3 2026 IND submission for its lead cell therapy candidate, ERNA-101.
No chart available for this instrument.